| CDK | cyclin-dependent kinase |
| CDKI | cyclin-dependent kinase inhibitor |
| EGFR | epidermal growth factor receptor |
| VEGFR | vascular endothelial growth factor receptor |
| FDA | the Food and Drug Administration of the United States |
| FGFR | fibroblast growth factor receptor |
| HER2 | human epidermal growth factor receptor-2 |
| NSCLC | non-small cell lung cancer |
| PDGFR | platelet-derived growth factor receptor |
| ATP | adenosine triphosphate |
| HDAC | Histone deacetylase |
| IC50 | inhibitory concentration |
| GI50 | half-maximum growth inhibition |
| PDB | Protein Data Bank |
| SAR | structure-activity relationship |
| WHO | World Health Organization |
| M phase | mitosis phase |
| RTK | receptor tyrosine kinase |
| MOA | Mechanism of action |
| Cancer Cell Lines Explanation | |
| A375 | melanoma |
| A431 | squamous |
| MDA-MB231 | breast |
| Colo205 | colon |
| HCT116 | colon |
| A549 | lung |
| MCF-7 | breast |
| PC3 | prostate |
| HepG2 | liver |
| MDA-MB-468 | breast |
| T-47D | breast |
| HeLa | cervical |
| K-562 | leukemia |
| A2780 | ovarian |
| HL60 | leukemia |
| HT-29 | colon |
| MOLT-4 | lymphoblastic leukemia |
| H460 | lung |
| SMMC77 | liver |
| MV4-11 | leukemia |
| SKOV3 | ovarian |
| WI-38 | lung |
| Panc-1 | pancreas |
| PaCa-2 | pancreas |
| BxPc-3 | pancreas |
| NCIH522 | lung |
| HCT-15 | colon |
| RKO | colon |
| SW480 | colon |
| DLD1 | colon |
| LO2 | liver |
| PC-9 | lung |
| HOP92 | lung |
| SNB-75 | brain |
| DU-145 | brain |